Assessing the in vivo data on low/no-calorie sweeteners and the gut microbiota

Auteur(s): Lobach AR, Roberts A, Rowland IR
Nom de la publication : Food and Chemical Toxicology (2019), doi: https://doi.org/10.1016/j.fct.2018.12.005
Année de publication : 2018

Abstract

Low/no-calorie sweeteners (LNCS) are continually under the spotlight in terms of their safety and benefits; in 2014 a study was published linking LNCS to an enhanced risk of glucose intolerance through modulation of the gut microbiota. In response, an in-depth review of the literature was undertaken to evaluate the major contributors to potential changes in the gut microbiota and their corresponding sequelae, and to determine if consuming LNCS (e.g., acesulfame K, aspartame, cyclamate, neotame, saccharin, sucralose, steviol glycosides) contributes to changes in the microbiome based on the data reported in human and animal studies. A few rodent studies with saccharin have reported changes in the gut microbiome, but primarily at high doses that bear no relevance to human consumption. This and other studies suggesting an effect of LNCS on the gut microbiota were found to show no evidence of an actual adverse effect on human health. The sum of the data provides clear evidence that changes in the diet unrelated to LNCS consumption are likely the major determinants of change in gut microbiota numbers and phyla, confirming the viewpoint supported by all the major international food safety and health regulatory authorities that LNCS are safe at currently approved levels.

Summary

This extensive review of the scientific literature concluded that current studies investigating the impact of low calorie sweeteners on gut microbiota show no evidence of any adverse effect on the gut microbiota at doses of low calorie sweeteners relevant to human consumption. Results of metabolism and safety studies show no evidence of a likely mechanism for a clinically relevant effect of low calorie sweeteners on gut microbiota.

The authors note that the reports of correlated effects primarily stem from animal studies where doses employed are beyond the possible expected intakes of humans, where there existed significant study design issues that make conclusions of effects questionable, or where data were incorrectly evaluated/ interpreted. Future studies evaluating the impact of food additive/ ingredient consumption on the gut microbiota need to be conducted in relevant animal models or clinical populations at relevant exposure levels and be carefully controlled to account for the presence of numerous confounding factors, including the habitual or background diet.

View full paper

Résumé de la politique de confidentialité

Ce site utilise des cookies afin que nous puissions vous fournir la meilleure expérience utilisateur possible. Les informations sur les cookies sont stockées dans votre navigateur et remplissent des fonctions telles que vous reconnaître lorsque vous revenez sur notre site Web et aider notre équipe à comprendre les sections du site que vous trouvez les plus intéressantes et utiles.

Cookies strictement nécessaires

Cette option doit être activée à tout moment afin que nous puissions enregistrer vos préférences pour les réglages de cookie.

Si vous désactivez ce cookie, nous ne pourrons pas enregistrer vos préférences. Cela signifie que chaque fois que vous visitez ce site, vous devrez activer ou désactiver à nouveau les cookies.

Cookies tiers

Ce site utilise Google Analytics pour collecter des informations anonymes telles que le nombre de visiteurs du site et les pages les plus populaires.

Garder ce cookie activé nous aide à améliorer notre site Web.